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Abstract	
Parallel single-cell sequencing protocols represent powerful methods for investigating 
regulatory relationships, including epigenome-transcriptome interactions. Here, we report a 
novel single-cell method for parallel chromatin accessibility, DNA methylation and 
transcriptome profiling. scNMT-seq (single-cell nucleosome, methylation and transcription 
sequencing) uses a GpC methyltransferase to label open chromatin followed by bisulfite and 
RNA sequencing. We validate scNMT-seq by applying it to differentiating mouse embryonic 
stem cells, finding links between all three molecular layers and revealing dynamic coupling 
between epigenomic layers during differentiation. 
  
Introduction	
Understanding regulatory associations between the epigenome and the transcriptome 
requires simultaneous profiling of multiple molecular layers. Previously, such multi-omics 
analyses have been limited to bulk assays, which profile ensembles of cells. These methods 
have been applied to study variation across individuals1, cell type2 or conditions by assessing 
links between different molecular layers. With rapid advances in single-cell technologies, it is 
now possible to leverage variation between single cells to probe regulatory associations within 
and between molecular layers. For example, we and others have established protocols that 
allow the methylome and the transcriptome or, alternatively, the methylome and chromatin 
accessibility to be assayed in the same cell3, 4, 5, 6, 7. However, it is well known that DNA 
methylation and other epigenomic layers, including chromatin accessibility, do not act 
independently of one another8. Consequently, the ability to profile, at single cell resolution, 
multiple epigenetic features in conjunction with gene expression will be critical for obtaining a 
more complete understanding of epigenetic dependencies and their associations with 
transcription and cell states9. 
To address this, we have developed a method that enables the joint analysis of the 
transcriptome, the methylome and chromatin accessibility. Our approach builds on previous 
parallel protocols such as single-cell methylation and transcriptome sequencing (scM&T-
seq3), in which physical separation of DNA and RNA is performed prior to a bisulfite conversion 
step and the cell’s transcriptome is profiled using a conventional Smartseq2 protocol10.  To 
measure chromatin accessibility together with DNA methylation, we adapted Nucleosome 
Occupancy and Methylation sequencing (NOMe-seq)11, where a methyltransferase is used to 
label accessible (or nucleosome depleted) DNA prior to bisulfite sequencing (BS-seq), which 
distinguishes between the two epigenetic states. In mammalian cells, cytosine residues in 
CpG dinucleotides can be abundantly methylated, whereas cytosines followed by either 
adenine, cytosine or thymine (collectively termed CpH) are methylated at a much lower rate12. 
Consequently, by using a GpC methyltransferase (M.CviPI) to label accessible chromatin, 
NOMe-seq can recover endogenous CpG methylation information in parallel. NOMe-seq is 
particularly attractive for single-cell applications since, contrary to count-based assays such 
as ATAC-seq or DNase-seq, the GpC accessibility is encoded through the bisulfite conversion 
and hence inaccessible chromatin can be directly discriminated from missing data. 
Importantly, this implies that the coverage is not influenced by the overall accessibility, so 
lowly accessible sites will not suffer from increased technical variation compared to highly 
accessible sites. Additionally, the resolution of the method is determined by the frequency of 
GpC sites within the genome (~1 in 16bp), rather than the size of a library fragment (>100bp). 
Recently developed single-cell NOMe-seq protocols have been applied to assess cell-to-cell 
variance in CTCF footprinting6 and to map chromatin remodeling during preimplantation 
development7. However, no method that combines RNA-seq with chromatin accessibility 
profiling in the same cells (with or without DNA methylation) has been reported to-date, which 
is critical for studying interactions between the epigenome and the transcriptome. 
Results	
scNMT-seq	robustly	profiles	gene	expression,	DNA	methylation	and	chromatin	accessibility	in	single	
cellsTo validate scNMT-seq, we applied the method to a batch of 70 serum-grown EL16 mouse 
embryonic stem cells (ESCs), together with four negative (empty wells) and three scM&T-seq 
controls (cells processed using scM&T-seq, i.e., without M.CviPI enzyme treatment). This 
facilitates direct comparison with previous methods for assaying DNA methylation and 
transcription in the same cell3, 12, as well as providing a control of bisulfite conversion efficiency 
within the experiment. We isolated cells into methyltransferase reaction mixtures using FACS, 
followed by the physical separation of the DNA and RNA prior to BS-seq and RNA-seq library 
preparation (see Fig. 1a for an illustration of the protocol). Alignment of the BS-seq data and 
other bioinformatics processing can be carried out using established pipelines, with the 
addition of a filter to discard G-C-G positions, for which it is intrinsically not possible to 
distinguish endogenous methylation from in vitro methylated bases (21% of CpGs genome-
wide). Similarly, we discard C-C-G positions to mitigate against possible off-target effects of 
the enzyme11 (27% of CpGs). In total, 61 out of 70 cells processed using scNMT-seq passed 
quality control for both BS-seq and RNA-seq (Methods, Supplementary Data 1). 
The requirement to filter out C-C-G and G-C-G positions from the methylation data reduces 
the number of genome-wide cytosines that can be assayed from 22 million to 11 million. 
However, despite this, a large proportion of genomic loci with regulatory roles, such as 
promoters and enhancers, can in principle be assessed by scNMT-seq (Fig. 1b). Consistent 
with this, we observed high empirical coverage for methylation: a median of ~50% of 
promoters, ~75% of gene bodies and ~25% of active enhancers are captured in a typical cell 
by at least 5 cytosines (Fig. 1c, Supplementary Fig. 1a). We also compared the methylation 
coverage to data from our previous BS-seq protocols that did not incorporate a DNA 
accessibility component3, again finding only small differences in coverage, albeit these 
became more pronounced when down-sampling the total sequence coverage (Supplementary 
Fig. 1b). Computational methods for imputing these missing values could help to further 
mitigate these differences13. Due to the higher frequency of GpC compared to CpG 
dinucleotides in the mouse genome, accessibility coverage was larger than that observed for 
endogenous methylation (Fig. 1b, c and Supplementary Fig. 1a). Using our data, a median of 
~85% of gene bodies and ~75% of promoters could be probed for DNA accessibility, the 
highest coverage achieved by any single-cell accessibility protocol to date (9.4% using 
scATAC-seq14, and with scDNase-seq, ~50% of genes >1 RPKM, >80% of genes >3 RPKM15).  
This coverage also compares favourably with other single-cell NOMe-seq methods developed 
in parallel, which report GpC site coverages of 2.9%6 and 10%7 compared to 15% using 
scNMT-seq (Supplementary Data 1). 
Next, we examined accessibility levels at loci with known regulatory roles. We found that 
accessibility was increased at known DNaseI hypersensitivity sites, super enhancer regions 
and binding sites for transcription factors and other DNA binding proteins (from published 
ChIP-seq data, Fig. 1d, Supplementary Fig. 2). As, a control, we included cells which did not 
receive enzyme treatment (scM&T-seq controls) and these cells showed universally low GpC 
methylation levels (~2%), with no enrichment at regulatory regions, indicating that the 
accessibility data are not affected by endogenous GpC methylation (Supplementary Fig. 3). 
We next stratified loci and cells based on the expression level of the nearest gene (based on 
the RNA data from the corresponding cell). In agreement with previous studies8, we observed 
that highly-expressed genes were associated with increased accessibility at promoters and at 
nearby regulatory sites, whereas lowly-expressed genes were associated with reduced 
accessibility (Fig. 1e; Supplementary Fig. 4).  
Next, to assess the quality of data obtained using scNMT-seq, we compared the 
transcriptome, methylome and accessibility profiles to published datasets. When considering 
the RNA-seq component, dimensionality reduction16 and hierarchical clustering revealed that 
cells cluster by condition and not by protocol (Supplementary Fig. 5). We next compared the 
methylome obtained from scNMT-seq to single-cell libraries profiled using scM&T-seq3, scBS-
seq12 and bulk BS-seq17, finding that most of the cell-to-cell variation is not attributed to 
protocol or study but to changes in the mean methylation rate (first principal component, 51% 
variance) (Supplementary Fig. 6). To validate the accessibility measurements, we generated 
a synthetic pseudo-bulk dataset by merging data from all cells, which we compared to 
published bulk DNase-seq data from the same cell type18. Globally, we observed high 
consistency between datasets (Relative accessibility profiles, Pearson R = 0.74, 
Supplementary Fig. 7). A notable difference was that scNMT-seq data captured, within single 
cells, oscillating profiles with peaks spaced ~180 to ~200bp apart, indicating the positions of 
nucleosomes (Fig. 1d,e and Supplementary Fig. 8), which is consistent with accessibility 
profiles obtained using bulk NOMe-seq11, demonstrating high resolution of our accessibility 
measurements.  
As a final quality assessment, we analysed associations between molecular layers within 
individual cells (across all genes), which is similar to approaches used to investigate linkages 
using bulk data (see Fig. 2 upper panel for a graphical representation). Reassuringly, this 
confirmed the expected negative correlations for methylation with transcription19 and 
methylation with accessibility8 (Fig. 2, lower panel) and positive correlations between 
accessibility and expression17 (for most genomic contexts with the notable exception of active 
enhancers for which there is little evidence for a correlation between accessibility and 
expression in our data or in published data). These results indicate that our method 
recapitulates, within single cells, known trends from bulk data.  
Taken together, these results demonstrate that our method is able to robustly profile gene 
expression, DNA methylation and chromatin accessibility within the same single cell. 
scNMT identifies loci with coordinated variability between different molecular layersHaving 
established the efficacy of our method, we next explored its potential for identifying loci with 
coordinated epigenetic and transcriptional heterogeneity. To obtain a dataset with a larger 
degree of heterogeneity than observed in ES cells, we prepared a second dataset obtained 
from serum grown ES cells that we removed from LIF for 3 days to initiate differentiation into 
embryoid bodies (EBs). We sequenced 43 cells, which clearly clustered into two sub-
populations based on RNA-seq profiles, corresponding to pluripotent and differentiating states 
(Supplementary Fig. 9). First, we examined cell-to-cell variance in the methylation data, finding 
that enhancers and Nanog binding sites were associated with the largest methylation 
heterogeneity, which is in agreement with previous ES cell data3, 12 (Supplementary Fig. 10a, 
10b). Conversely, variability in accessibility rates was either at similar levels to the background 
or, in the case of promoters, CGIs, active enhancers, and gene bodies, found to be reduced 
relative to the background (Supplementary Fig. 10c, 10d). This could indicate that there are 
genomic elements which limit variability of chromatin accessibility, such as CGIs most of which 
in a cell are constitutively accessible 20. 
Subsequently, we tested locus-specific associations between different pairwise combinations 
of molecular layers (Fig. 3a), which is distinct from the correlations across genes used for 
quality control above and is enabled by parallel single-cell measurements in multiple cells. 
This analysis can be used to discover individual genes and loci with coordinated heterogeneity 
across pairs of molecular layers. First, considering associations between methylation and 
transcription, we identified a minimum of 3 (exons) and a maximum of 47 (gene bodies) 
associations (FDR<0.1, Fig. 3a, Supplementary Fig. 11a, Supplementary Data 2, Methods). 
The majority of these associations were negative, reflecting the known relationship between 
these two layers. In contrast, we found that associations between DNA accessibility and 
transcription were less widespread, with a small number of mostly positive associations in 
promoters, p300 binding sites and super enhancer regions (13 associations total, FDR< 0.1, 
Fig. 3a, Supplementary Fig. 11b and Supplementary Data 2). Low numbers of correlated 
accessibility – expression could indicate that transcriptional changes in this population are 
more dependent on DNA methylation changes than chromatin accessibility changes and this 
is in agreement with the results presented in Fig. 2. Finally, for methylation-accessibility, we 
found associations at most genomic contexts, with up to 89 significant correlations (introns) 
and these tended to be negative as expected (Fig. 3a, Supplementary Fig. 11c and 
Supplementary Data 2). 
As an illustrative example, Fig. 3b displays the Esrrb locus, a gene we find to be expressed 
primarily in the pluripotent cells (Supplementary Fig. 9), and which displays a strong 
correlation between methylation and expression in super enhancer regions, replicating 
previous findings3. Mean methylation and accessibility rates along the gene showed clear 
differences between the two sub-populations of cells identified, which were largest at 
regulatory elements. While the super enhancers showed the strongest negative correlation 
between methylation and transcription, a strong positive correlation was found in the promoter 
between accessibility and transcription. Similarly, Supplementary Fig. 12 shows the Prtg 
locus, a known neuroectoderm marker21, which is expressed primarily in differentiated cells 
(Supplementary Fig. 9), again showing marked epigenetic differences between the two cell 
populations. 
scNMT-seq captures single base resolution of chromatin accessibility profiles in single cells 
Inspection of accessibility data at the single GpC level reveals complex patterns due to 
presence of nucleosomes (Fig. 1d and 1e), which are not appropriately captured by rate 
parameters calculated in predefined windows. The prevalence of these oscillatory patterns 
prompted us to reconstruct the DNA accessibility profiles in individual cells at a locus level, by 
adapting a statistical model initially developed for DNA methylation profiles22. As expected, 
the single-cell profiles at gene promoters were more predictive of gene expression than 
conventional accessibility rates (Supplementary Fig. 13), and these captured characteristic 
patterns of nucleosome depleted regions at transcription start sites and cell-to-cell variation in 
both the position and the number of nucleosomes (see Supplementary Fig. 14). 
Next, we exploited the reconstructed profiles to quantify the level of heterogeneity of chromatin 
accessibility at transcription start sites. For each gene, we clustered the cells based on the 
similarity of the accessibility profiles and we estimated the most likely number of clusters 
(Methods). Subsequently, we stratified genes by the number of clusters estimated by our 
model, which we considered as a measure of accessibility heterogeneity (Fig 4a). This 
revealed that genes with homogeneous accessibility profiles (fewer clusters) were associated 
with higher average expression levels (Fig. 4b) and were enriched for gene ontology terms 
linked to house-keeping functions, such as regulation of gene expression, rRNA processing 
and splicing (Fig 4d). Examples of genes with a single cluster are shown in Supplementary 
Fig. 15 and examples of genes with two differentially expressed clusters are shown in 
Supplementary Fig. 16. In contrast, genes with heterogeneous accessibility (multiple clusters) 
were associated with low expression levels and were enriched for bivalent promoters 
containing both active H3K4me3 and repressive H3K27me3 histone marks (Fig. 4c). The 
increased bivalency was independent of the mean expression level of the gene 
(Supplementary Fig. 17).  
scNMT-seq captures epigenome dynamics along a developmental trajectory 
One of the most interesting opportunities of scNMT-seq is to link epigenetic properties to the 
transcriptomic profile along dynamic trajectories of different cell states. To explore this, we 
used the RNA-seq component to reconstruct a pseudotemporal ordering of the cells from 
pluripotent to differentiated cell states (Fig. 5a, Methods). We then tested for coordinated 
changes between the accessibility profiles and the cellular position in the differentiation 
trajectory, which identified a set of 15 genes that showed a coherent dynamic pattern 
(Supplementary Fig. 18, Methods). Fig. 5b depicts two representative genes: Efhd1, a gene 
that displays a transition from a state with an open transcription start site (TSS) to a state with 
a closed TSS; and Rock2, with a similar transition on the +1 nucleosome after the TSS. 
Supplementary Fig. 19 shows additional examples of genes with associations between 
accessibility profile and pseudotime trajectory. 
Finally, we investigated whether dynamic changes in the coupling between the epigenetic 
layers are observed along the differentiation trajectory. To this end, we plotted methylation-
accessibility correlation coefficients (as calculated in Fig. 2a) against pseudotime, which 
revealed an increasing negative correlation coefficient between DNA methylation and 
accessibility in practically all genomic contexts (Fig. 5c). Notably, this suggests that the 
coupling between the epigenetic layers increases as cells commit to downstream lineages, 
which could be an important step in lineage priming. Importantly, this analysis was made 
possible by the continuous nature of the single-cell pseudotime ordering and the ability to 
profile the three molecular layers and highlights the utility of such parallel single-cell 
techniques.  
In conclusion, we have described a method for parallel single-cell DNA methylation, gene 
expression and high-resolution chromatin accessibility measurements and report novel 
associations between each molecular layer. We additionally show that our method can be 
used to dissect the dynamics of epigenome interactions during a developmental trajectory. 
This method will greatly expand our ability to investigate relationships between the epigenome 
and transcriptome in heterogeneous cell types and across developmental and other cell fate 
transitions. 
Methods	
Experimental	design	
No statistical methods were used to predetermine sample size. The experiments were not 
randomised. The investigators were not blinded to allocation during experiments and 
outcome assessment.  
Cell	culture	
El16 mESCs were derived from a 129xCast/129 embryo previously23 and cultured in serum 
containing media (DMEM 4,500 mg/l glucose, 4 mM L-glutamine, 110 mg/l sodium pyruvate, 
15% fetal bovine serum, 1 U/ml penicillin, 1 μg/ml streptomycin, 0.1 mM nonessential amino 
acids, 50 μM β-mercaptoethanol, and 103 U/ml LIF ESGRO) without feeders. E14 mESCs 
(the E14 cell line was a generous gift from A. Smith) were cultured as EL16 then seeded into 
low attachment plates at 1000 cells mL-1 in serum media without LIF for 3 days before 
collection. Single cells were collected by FACS, selecting for live cells and low DNA content 
(i.e., G0 or G1 phase cells) using ToPro-3 and Hoechst 33342 staining to select for live cells 
with low DNA content (i.e. G0 or G1 phase cells). The cell lines were subjected to routine 
mycoplasma testing using the MycoAlert testing kit (Lonza). 
Library	preparation	
Cells were collected directly into 2.5μl methyltransferase reaction mixture which was 
comprised of 1x M.CviPI Reaction buffer (NEB), 2U M.CviPI (NEB), 160 μM S-
adenosylmethionine (NEB), 1U μl-1 RNAsein (Promega), 0.1% IGEPAL (Sigma) then 
incubated for 15 minutes at 37°C. The reaction was stopped and the RNA preserved with the 
addition of 5μl RLT plus (Qiagen) prior to scM&T-seq library preparation according to the 
published protocols for G&T-seq24, 25 and scBS-seq26 with minor modifications. Briefly, mRNA 
was captured using Smart-seq210, 27 oligo-dT pre-annealed to magnetic beads (MyOne C1, 
Invitrogen). The lysate containing the gDNA was transferred to a separate PCR plate and the 
beads were washed three times in 15μl of 1x FSS buffer (Superscript II, Invitrogen), 10mM 
DTT, 0.005% tween-20 (Sigma) and 0.4U μl-1 of RNAsin (Promga). After each wash, the 
solution was transferred to the DNA plate to maximise recovery. The beads were then 
resuspended in 10 μl of reverse transcriptase mastermix (100 U SuperScript II (Invitrogen), 
10 U RNAsin (Promega) 1x Superscript II First-Strand Buffer, 2.5mM DTT (Invitrogen), 1M 
betaine (Sigma), 9mM MgCl2 (Invitrogen), 1 uM Template-Switching Oligo10, 27 (Exiqon), 1mM 
dNTP mix (Roche)) and incubated on a thermocycler for 60 min at 42 °C followed by 30 min 
at 50 °C and 10 min at 60 °C. PCR was then performed by adding 11 μl of 2x KAPA HiFi 
HotStart ReadyMix and 1μl of 2 uM ISPCR primer10, 27 and cycling as follows: 98 °C for 3 min, 
then 18 cycles of 98 °C for 15 s, 67 °C for 20 s, 72 °C for 6 min and finally 72 °C for 5 min. 
cDNA was purified using a 1:1 volumetric ratio of Ampure Beads (Beckman Coulter) and 
eluted into 20μl of water. Libraries were prepared from 100 to 400pg of cDNA using the  
Nextera XT Kit (Illumina), per the manufacturer's instructions but with one-fifth volumes. In 
parallel, the genomic DNA was purified with a 0.8:1 volumetric ratio of Ampure XP Beads 
(Beckman Coulter) and eluted into 10μl of water. Bisulfite conversion was carried out using 
EZ Methylation Direct MagBead kit (Zymo) according the manufacturers’ instructions but with 
half volumes. Converted DNA was eluted into 40μl of first strand synthesis mastermix (1x Blue 
Buffer (Enzymatics), 0.4mM dNTP mix (Roche), 0.4uM 6NF oligo (IDT) then heated to 65°C 
for 3 minutes and cooled on ice. 50U of klenow exo- (Enzymatics) was added and the mixture 
incubated on a thermocycler at 37°C for 30 minutes after slowly ramping from 4°C. First strand 
synthesis was repeated 4 more times with the addition of 0.25 μl of reaction mixture (1x blue 
buffer, 0.25mM dNTPs, 10mM 6NF oligo and 25U klenow exo-). Reactions were diluted to 
100μl and 20U of exonuclease I (NEB) added and incubated at 37°C before purification using 
a 0.75:1 ratio of AMPure XP beads. Purified products were resuspended in 50μl of second 
strand mastermix (1x Blue Buffer (Enzymatics), 0.4mM dNTP mix (Roche), 0.4uM 6NF oligo 
(IDT) then heated to 98°C for 2 minutes and cooled on ice. 50U of klenow exo- (Enzymatics) 
was added and the mixture incubated on a thermocycler at 37°C for 90 minutes after slowly 
ramping from 4°C. Second strand products were purified using a 0.75:1 ratio of AMPure XP 
beads and resuspended in 50μl of PCR mastermix (1x KAPA HiFi Readymix, 0.2uM PE1.0 
primer, 0.2uM iTAG index primer) and amplified with 14 cycles. Finally, scBS-seq libraries 
were purified using a 0.7:1 volumetric ratio of AMPure XP beads before pooling and 
sequencing. 
Sequencing	EL16	serum	ES	cells	
20 of the BS-seq libraries, including 3 negative controls, were initially sequenced on a 50bp 
single-end MiSeq run to assess quality. The negative controls were found to have substantially 
reduced mapping efficiencies compared to the single cell samples (mean of 2.7% compared 
to 36.8%, see Supplementary Data 1). All single-cell BS-seq libraries were subsequently 
sequenced to a mean depth of 16.1 million paired-end reads and RNA-seq libraries were 
sequenced to a mean depth of 2.0 million paired-end reads. Both sets of libraries were 
sequenced on HiSeq 2500 instruments using v4 reagents and 125bp read length. 
Sequencing		E14	embryoid	body	cells	
48 BS-seq libraries were sequenced as a multiplex on one 75bp PE high-output run on an 
Illumina NextSeq500 with a mean sequencing depth of 9.6 million per cell. RNA-seq libraries 
were sequenced on an Illumina NextSeq500 with a mean depth of 1.0 million 75 bp single-
end reads per cell (Supplementary Data 1). 
BS-seq	alignment	
Single-cell bisulfite libraries were processed using Bismark28 as described26 with the additional 
--NOMe option in the coverage2cytosine script which produces CpG report files containing 
only A-C-G and T-C-G positions and GpC report files containing only G-C-A, G-C-C and G-C-
T positions.   
RNA-seq	alignment		
Single-cell RNA-seq libraries were aligned using HiSat229 using options --dta --sp 1000,1000 
--no-mixed --no-discordant for the paired-end ES cell libraries and --dta --sp 1000,1000 for the 
single-end EB cell libraries. 
Quality	control	–	RNA-seq	
For the EL16 serum grown ES cells, we discarded cells that had (1) less than 300,000 reads 
mapped (2) more than 15% of total reads mapped to mitochondrial genes, (3) less than 2,000 
genes expressed. In total, 68 cells passed the quality control (Supplementary Fig. 20a).  
For the E14 embryoid body cells, we used a lower read-depth cut-off due to the lower 
sequencing depth employed, discarding cells that had (1) less than 100,000 reads mapped 
(2) more than 15% of total reads mapped to mitochondrial genes, (3) less than 2,000 genes 
expressed. In total, 46 cells passed the quality control (Supplementary Fig. 20b).  
Quality	control	–	BS-seq	
For the EL16 serum grown ES cells, we discarded cells that had (1) less than 10% mapping 
efficiency (2) less than 500,000 CpG sites or 5,000,000 GpC sites covered. We additionally 
excluded one cell with unusually high CpG coverage (>5M) and low duplication (26%) as a 
possible doublet. In total, 64 cells out of 73 passed the quality control (Supplementary Fig. 
21a, Supplementary Data 1). All 64 cells also passed RNA-seq QC (88%) and these 
comprised 61 scNMT-seq cells and 3 scM&T-seq cells. 
For the E14 EB cells, we again used a lower coverage cutoff due to lower sequencing depth, 
discarding cells that had (1) less than 10% mapping efficiency (2) less than 300,000 CpG sites 
covered. In total, 40 cells passed the quality control (Supplementary Fig. 21b, Supplementary 
Data 1), all of which also passed RNA-seq QC and comprised 33 scNMT-seq cells and 7 
scM&T-seq cells.	
CpG	Methylation	and	GpC	accessibility	quantification	
Following the approach of Smallwood et al12, individual CpG or GpC sites in each cell were 
modelled using a binomial model where the number of successes is the number of reads that 
support methylation and the number of trials is the total number of reads. A CpG methylation 
or GpC accessibility rate for each site and cell was calculated by maximum a posteriori 
assuming a beta prior distribution. Subsequently, CpG methylation and GpC accessibility rates 
were computed for each genomic feature assuming a normal distribution across cells and 
accounting for differences in the standard errors of the single site estimates. See 
Supplementary Data 3 for details of genomic contexts used in this study. 
RNA	quantification	
Gene expression counts were quantified from the mapped reads using featureCounts30. Gene 
annotations were obtained from Ensembl version 8731. Only protein-coding genes matching 
canonical chromosomes were considered. Following32 the count data was log-transformed 
and size-factor adjusted based on a deconvolution approach that accounts for variation in cell 
size33. 
Methylation	and	accessibility	pseudo-bulk	profiles	
Methylation and accessibility profiles were visualised by taking predefined windows around 
the genomic context of interest. For each cell and feature, methylation and accessibility values 
were averaged using running windows of 50 bp. The information from multiple cells was 
combined by calculating the mean and the standard deviation for each running window. Genes 
were split into three classes according to a histogram of the log2 normalised counts (x): Low 
(x<2), Medium (2<x<6) and High (x>6). All genomic features were associated to the closest 
gene within a 5kb window (upstream and downstream of gene start and stop). 
Single-cell	accessibility	profiles	
Accessibility profiles were constructed within each cell and gene in +/-200bp windows around 
the TSS (as displayed in Fig 5b and Supplementary Fig. 14, 15 and 16) using a generalised 
linear model (GLM) of basis function regression coupled with a Bernoulli likelihood using 
BPRMeth22. We only considered genes that were covered in at least 40% of the cells with a 
minimum coverage of 10 GpC sites. Subsequently, we clustered the profiles for each gene by 
fitting a finite mixture model using an expectation–maximization (EM) algorithm. We estimated 
the most likely number of clusters based on the Bayesian Information Criterion (BIC). The 
number of clusters was used as a measure of cell-to-cell variation in the accessibility profile; 
the rationale being that homogeneous profiles will be grouped in a single cluster, while regions 
with heterogeneous profiles will be assigned a higher number of clusters. Gene Ontology 
enrichment was performed for the different clusters using Fisher's exact test. The p-values 
where corrected by multiple testing using False Discovery Rate. 
Predicting	expression	
To compare the performance of using accessibility rates versus profiles for predicting gene 
expression levels we used the same approach described in22. We first computed the 
accessibility rates and profiles for each gene and cell. Then, for each cell, we used the fitted 
values as input features to a regression model with the gene expression levels as the response 
variable. To measure the accuracy of the model we computed the Pearson's correlation 
coefficient between the observed and predicted expression levels (Supplementary Fig. 13a) 
To account for the different number of features used in the two models (i.e. rate vs profile 
features) we also computed the adjusted R2 (Supplementary Fig. 13b) 
Correlation	analysis	
For the correlation analysis across cells, genes with low expression levels and low variability 
were discarded, according to the rationale of independent filtering34. Only the top 50% of the 
most variable loci were considered for analysis and a minimum number of 20 cells was 
required to compute a correlation. A minimum coverage of 3 sites was required per feature. 
All genomic features were associated to the closest gene within a 10kb window (upstream and 
downstream of gene start and stop). Following our previous approach3, we tested for linear 
associations by computing a weighted Pearson correlation coefficient, thereby accounting for 
differences in the coverage between cells. When assessing correlations between GpC 
accessibility with CpG methylation, we used the average CpG methylation coverage as a 
weight. Two-tailed Student’s t-tests were performed to test for nonzero correlation, and P-
values were adjusted for multiple testing for each context using the Benjamini-Hochberg 
procedure. For promoter annotations, we used a small window for accessibility (+/- 50bp) to 
focus our analysis on the transcription start site whereas for methylation we considered a 
larger window (+/- 2kb). This choice was informed by pseudo-bulking the single-cell data and 
computing the correlation between accessibility/methylation and gene expression (across 
genes) for small 50bp windows along the promoter, finding that the strongest signal fell within 
our chosen range (Supplementary Fig. 22). 
Pseudotemporal	ordering	of	cells	
Cells were ordered along a putative developmental trajectory (pseudotime) with the destiny 
package 35, using the top 500 genes with most biological overdispersion as estimated by the 
scran package. 
Code availability 
All R code is provided as Supplementary Software and is available from 
https://github.com/PMBio/scNMT-seq/ 
Data availability 
Raw sequencing data together with processed files (RNA counts, CpG methylation reports, 
GpC accessibility reports) are available in the Gene Expression Omnibus under accession 
GSE109262. 
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Figure	Legends	
Figure 1. scNMT-seq overview and genome-wide coverage. (a) Protocol overview. Single-cells are lysed and 
accessible DNA is labelled using GpC methyltransferase. RNA is then separated and sequenced using Smart-
seq2, whilst DNA undergoes scBS-seq library preparation and sequencing. Methylation and chromatin accessibility 
data are separated bioinformatically. (b) Theoretical maximum CpG coverage of genomic contexts with known 
regulatory roles. Shown is the proportion of loci in different contexts that contain at least 5 cytosines. ‘All CpG’ 
considers any C-G dinucleotides (e.g. as in scBS-seq), ‘NOMe-seq CpG’ considers A-C-G and T-C-G trinucleotides 
and ‘NOMe-seq GpC’ considers G-C-A, G-C-C and G-C-T trinucleotides. (c) Empirical coverage in 61 mouse ES 
cells considering the same contexts as in b. Shown is the coverage distribution across cells after QC; box plots 
show median coverage and the first and third quartile, whiskers show 1.5 x the interquartile range above and below 
the box. (d) CpG methylation and GpC accessibility profiles at published DNase hypersensitive sites18. The profiles 
were computed as a running average in 50bp windows. Shading denotes standard deviation across cells. (e) CpG 
methylation and GpC accessibility profiles at gene promoters. Promoters are stratified by average expression level 
of the corresponding gene (log normalised counts less than 2 (low), between 2 and 6 (medium) and higher than 6 
(high). The profile is generated by computing a running average in 50bp windows. 
	
Figure 2. scNMT-seq recapitulates known global associations between molecular layers. Upper panel shows 
an illustration of the computation of the correlation across genes (one association test per cell). Left is CpG 
methylation and RNA expression associations, middle is CpG methylation and GpC accessibility associations, and 
right is GpC accessibility and RNA expression associations. Red circles represent CpG methylation levels, blue 
circles represent GpC accessibility levels and yellow polyA tails represent RNA abundance. Lower panel shows 
the Pearson correlation coefficients between molecular layers at different genomic contexts in the ESC data. Box 
plots show the distribution of correlation coefficients in single cells. Boxes display median coverage and the first 
and third quartile, whiskers show 1.5 x the interquartile range above and below the box. Dots show the correlation 
coefficient in the pseudo-bulked data estimated as average across all single-cells. Stars show the correlation 
coefficient using published bulk data from the same cell type17, 18. Sample size for the single-cell data is determined 
by the number of cells which pass QC for both layers (61 – 64 cells, see Methods). 
	
Figure 3. scNMT-seq enables the discovery of novel associations at individual loci. (a) Left panel shows an 
illustration for the correlation analysis across cells, which results in one association test per locus. The right panel 
shows the Pearson correlation coefficient (x-axis) and log10 p-value (y-axis) from association tests between 
different molecular layers at individual loci, stratified by genomic contexts. Significant associations (FDR<0.1, 
Benjamini-Hochberg adjusted), are highlighted in red. The number of significant positive (+) and negative (−) 
associations and the number of tests (centre) are indicated above. Sample size varies depending on the number 
of cells, which have coverage for a specific loci (see Methods). (b) Zoom-in view of the Esrrb gene locus. Shown 
from top to bottom are: Pairwise Pearson correlation coefficients between each pair of the three layers (Met, 
methylation; Acc, accessibility; Expr, expression). Accessibility (blue) and methylation (red) profiles shown 
separately for pluripotent and differentiated sub-populations; mean rates (solid line) and standard deviation (shade) 
were calculated using a running window of 10kb with a step size of 1000bp; Track with genomic annotations, 
highlighting the position of regulatory elements: promoters, super enhancers, and p300 binding sites. 
Figure 4. Modelling chromatin accessibility profiles at gene promoters in single cells. (a) Accessibility 
profiles for each cell and gene are fitted at a single nucleotide resolution (+-200bp around the TSS), followed by 
clustering of profiles for each gene to estimate the most likely number of clusters. Genes with higher numbers of 
clusters correspond to genes with increased heterogeneity compared to genes with small numbers of clusters. (b) 
Relationship between heterogeneity in the accessibility profile and gene expression. Boxplots show the distribution 
of average gene expression levels for genes with increasing numbers of accessibility clusters. Upper and lower 
hinges display third and first quartiles; the bar displays the median and the whiskers 1.5 times the inter-quartile 
range above and below the boxes. (c) Proportion of gene promoters marked with H3K4me3 and/or H3K27me3 
stratified by number of accessibility clusters. Promoters with high levels of accessibility heterogeneity are 
associated with the presence of bivalent histone marks (both H3K4me3 and H3K27me3). (d) Gene ontology terms 
significantly enriched in genes with most homogeneous accessibility profiles (K=1).   
Figure 5. Using scNMT-seq to explore dynamics of the epigenome during differentiation. (a) Embryoid body 
cells ordered in a developmental trajectory inferred from the RNA-seq data. Shown is the location of each cell in 
pseudotime (x axis) versus the expression level of Esrrb (y axis). (b) Reconstructed dynamics of variation in 
chromatin accessibility profiles across the developmental trajectory. Shown are profiles of representative cells for 
Rock2 and Efhd1. Axis ticks display -200bp, 0bp and +200bp relative to the TSS. Shading is used to highlight 
changes between cells. (c) Developmental trajectory is associated changes in genome-wide methylation-
accessibility coupling. Shown is the location of each cell in pseudotime (x axis) and the corresponding Pearson 
correlation coefficients between methylation and accessibility (y axis) in different genomic contexts. 
 
 
